Sat.Feb 17, 2024 - Fri.Feb 23, 2024

article thumbnail

Full Scope of Pharmacy Practice: Reinventing the Future and Overcoming Barriers

Pharmacy Times

The full scope of pharmacy practice offers a transformative approach to health care delivery, promising improved patient outcomes, greater access to care, and efficient utilization of health care resources.

139
139
article thumbnail

What are consumers’ attitudes about OTCs?

Drug Store News

Recent data from YouGov Profiles reveals that nearly half of Americans (47%) buy OTC drugs as required rather than stocking up, followed by 39% who keep a stock of medications but buy others when necessary.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Stealing With Our Eyes Open

Drug Topics

How much longer can independent pharmacists survive with the current method of reimbursement?

275
275
article thumbnail

STAT+: UnitedHealth cyberattack cripples pharmacies’ and hospitals’ ability to process insurance claims

STAT

Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam after UnitedHealth Group disclosed a cyberattack within a recently acquired subsidiary that serves as a central hub for payments across the industry. The cyberattack and subsequent system outage within UnitedHealth’s Change Healthcare has caught the attention of federal law enforcement agencies.

Insurance 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

California Passes First-in-Nation Law to Reduce Medication Errors, Address Pharmacy Staffing Concerns

Pharmacy Times

California's Stop Dangerous Pharmacies Act aims to improve patient safety by establishing new pharmacy staffing regulations and a medication error reporting system, arising from understaffed conditions.

156
156
article thumbnail

Abridge clinches $150M to build out generative AI for medical documentation

Fierce Healthcare

Investors continue to pour money into generative AI startups and Abridge is riding this wave as it rapidly scales its technology across U.S. health systems. | Along with the funding round, Abridge also announced an enterprise agreement with Connecticut-based Yale New Haven Health System to give thousands of clinicians access to its AI-powered clinical documentation technology.

More Trending

article thumbnail

Florida policy set amid measles outbreak alarms vaccination proponents

STAT

A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea

Vaccines 145
article thumbnail

All Pharmacies Are Not the Same: Community Pharmacy Quality

Pharmacy Times

Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.

article thumbnail

Optum's Change Healthcare responding to 'cybersecurity issue'

Fierce Healthcare

Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant. | Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant.

140
140
article thumbnail

How Technology Has Changed the Pharmacy Landscape

Drug Topics

During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy.

196
196
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Presidential age debate obscures a simple fact: Some cognitive skills improve as we get older

STAT

When a psychology professor in Michigan looked through his data on interpersonal conflict a decade ago, he discovered something unexpected. The study , which examined differences across cultures and age groups, seemed to show Americans got wiser as they got older. Richard Nisbett was used to research showing poorer mental skills among elderly adults, but his work found they were better at recognizing multiple perspectives, encouraging compromise, and acknowledging the limits of their own knowled

145
145
article thumbnail

The Pharmacy Industry Then and Now: How the Field Has Evolved Over Time

Pharmacy Times

The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.

149
149
article thumbnail

The opportunities and challenges facing rare disease therapies developers

pharmaphorum

Explore the opportunities and challenges facing rare disease therapies developers, including the impact of Rare Disease Day, FDA regulations, and cutting-edge technologies like CRISPR gene therapy.

FDA 138
article thumbnail

Lecanemab-irmb Approved for Alzheimer Disease

Drug Topics

On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.

FDA 185
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Opinion: The Alabama IVF ruling uses faux scientific language to justify a religious position

STAT

Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.

145
145
article thumbnail

AHIP, AMA and employer groups team up to accelerate digital health adoption

Fierce Healthcare

Fourteen organizations representing providers, payers, consumer technology companies and employers are teaming up to cut through the noise and raise higher standards for finding digital health | Fourteen organizations representing providers, payers, consumer technology companies and employers are teaming up to cut through the noise and raise higher standards for finding digital health solutions that work and are worth the investment.

131
131
article thumbnail

FDA Accepts Priority Review for Linvoseltamab to Treat Adult Patients With R/R MM

Pharmacy Times

Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.

FDA 123
article thumbnail

Breakthrough Vaccine for Chronic Hepatitis B Enters First In-Human Trial

Drug Topics

With over 3% of the world’s population affected by chronic hepatitis B, TherVacB has the potential to address a critical unmet need for a cure.

Vaccines 201
article thumbnail

NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease

STAT

Alison Sbrana was in the belly of an opera when her life changed. Down in the pit, surrounded by fellow orchestra members, she’d been straining to play her flute for half the show. As performers overhead enveloped the audience in arias, Sbrana felt like the Hulk was pulling on the tendons in the right side of her neck. “I begged anybody for meds at intermission,” she said.

article thumbnail

UnitedHealth, HAC study: How social health factors impact employer plans

Fierce Healthcare

Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper. | Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper.

125
125
article thumbnail

The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies

Pharmacy Times

Matthew Pianko, MD, outlines the logistical considerations involved when implementing bispecific antibodies for the treatment of multiple myeloma, including the roles of the project champion and other stakeholders as part of a multidisciplinary team.

120
120
article thumbnail

Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple Myeloma

Drug Topics

The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.

FDA 187
article thumbnail

Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb

STAT

SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco skyline. Its warmth did not reach the operating room tucked into the sprawling Parnassus Heights hospital complex. In there, the light was all cold and blue fluorescence washing over the sea of scrub caps huddled around an anesthetized young woman on a gurney.

Hospitals 145
article thumbnail

Roche’s Xolair is first medicine for food allergy in US

pharmaphorum

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people with food allergies in the US.

126
126
article thumbnail

Offering Children Vegetables at Breakfast Could Boost the Likelihood That They Grow to Like Them

Pharmacy Times

The practice could become routine if parents promote morning vegetable consumption while the children are still in a developmental stage of life.

132
132
article thumbnail

Repeat Dosing Study Demonstrates Positive Data for Neffy Epinephrine Nasal Spray

Drug Topics

Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.

232
232
article thumbnail

STAT+: Scientists take a (small) step toward universal antivenom

STAT

Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of sub-lethal doses of venom from various local snakes, wait for them to develop an immune response, tap their blood, purify out antibodies, bottle, and freeze. This vampiric, century-old process still reigns because of the unique scientific challenge posed by snake venoms.

article thumbnail

Clinical research is about trial and error

pharmaphorum

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

124
124
article thumbnail

Study: Gastric Bypass Surgery Put Approximately 75% of Patients With Type 2 Diabetes Into Remission

Pharmacy Times

Nearly 60% of patients who regained all the weight stayed in remission at 5 years post-surgery, according to study results.

145
145
article thumbnail

Heart Attack Linked With Higher Risk of Other Long-Term Health Conditions

Drug Topics

After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.

187
187
article thumbnail

Opinion: New CMS rules will throttle access researchers need to Medicare, Medicaid data

STAT

Groundbreaking research more than a decade ago showed that almost one-fifth of people enrolled in Medicare were being readmitted within 30 days after being discharged from the hospital, harming patients and increasing costs. That study led to a sea change in health care. The government started closely monitoring readmission rates and imposing fines on hospitals with high rates.

Hospitals 145
article thumbnail

Transforming clinical data management systems for biotechnology trials

pharmaphorum

Learn how biotechnology trials are transforming clinical data management systems, leveraging machine learning and advanced protocols to enhance efficiency and accuracy in data collection and analysis.

124
124
article thumbnail

Medicare Advantage fraud in DOJ's crosshairs after agency reports $2.7 billion in settlements

Fierce Healthcare

Under the False Claims Act, more than $1.8 billion in settlements and judgments was related to health-related matters in the last fiscal year, about two-thirds of the monetary fraud recoveries by t | Health fraud settlements under the False Claims Act exceeded $1.8 billion last year, according to the Department of Justice. The agency said it is still litigating Medicare Advantage cases against major insurers.

Insurance 118
article thumbnail

Differentiate Your Pharmacy With Unique Product, Service Offerings

Drug Topics

Offering services such as point-of-care testing and bundled products marketed as recovery kits can increase customer loyalty.

152
152